A booster dose of Johnson & Johnson’s Covid-19 vaccine sharply increased levels of antibodies against the coronavirus, according to interim data from two small, early-stage trials, the company said in a press release on Aug. 25.
Ion channels may be the Achilles’ heel of the SARS-CoV-2 virus, with research emerging from Israel that identified eight already-approved compounds that inhibit the activity of the E-protein channels in the virus’ membrane.
Arkansas nearly out of ICU beds as Delta variant fuels U.S. pandemic
Arkansas, Coronavirus Disease (COVID-19) Pandemic, COVID-19 vaccination rates, Delta Variant (B.1.617.2; India), Florida, Greg Abbott (Texas), Hospitalized COVID-19 Patients, Intensive Care Units (ICUs), Louisiana, Novel Coronavirus, Texas, United StatesOnly eight intensive care unit beds were available on Aug. 9 in Arkansas, the state’s governor said, as the rapid spread of the Delta variant of the coronavirus pushed cases and hospitalizations in the United States to a six-month high.
Inovio Pharmaceuticals Inc. is focused on launching the global late-stage trial of the company’s Covid-19 vaccine candidate in September 2021, chief executive Joseph Kim said in a call, with the drug developer expecting trial data in the first half of 2022.
Johnson & Johnson’s Covid-19 vaccine is working well in South Africa, offering protection against severe disease and death, the co-head of a trial in the country said on Aug. 6.
China rejected on July 22 a World Health Organization (WHO) plan for a second phase of an investigation into the origin of the coronavirus, which includes the hypothesis it could have escaped from a Chinese laboratory, a top health official said.
The next Covid pandemic could be prevented by using a gene drive to preemptively edit the genome of bats to prevent them from becoming hosts for coronaviruses, according to a proposal by scientists from Israel’s Interdisciplinary Center (IDC) Herzelia and the National Institutes of Health (NIH).
The Delta variant is already the dominant strain of Covid-19 in the United States, according to data modeling done by the U.S. Centers for Disease Control and Prevention (CDC).
Britain said on July 7 the country would provide genomic sequencing support to Brazil, Ethiopia, Kenya, Nigeria and Pakistan to help identify, assess and track new variants of the novel coronavirus.
Experimental prostate cancer drug may improve Covid-19 survival; younger patients report long lasting symptoms
Brazil, Clinical Trials, COVID-19 Studies, Covid-19 Variants, Delta Variant (B.1.617.2; India), Hospitalized COVID-19 Patients, Nature Medicine, Norway, Novel Coronavirus, Prostate Cancer, R&DIn a roundup of scientific studies on the novel coronavirus and efforts to find treatments and vaccines, a prostate cancer drug improved Covid-19 survival in a clinical trial and mildly ill young Covid-19 patients reported lasting symptoms in another study.